1 / 25

Opioids in Chronic Pain Management

Opioids in Chronic Pain Management. Benefits and Risks Side effects: constipation, sleep disruption, altered mental status, itching, nausea, respiratory depression Addiction vs. Dependence Assessing whether medication improves quality of life and participation in life or diminishes them.

kin
Download Presentation

Opioids in Chronic Pain Management

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Opioids in Chronic Pain Management • Benefits and Risks • Side effects: constipation, sleep disruption, altered mental status, itching, nausea, respiratory depression • Addiction vs. Dependence • Assessing whether medication improves quality of life and participation in life or diminishes them

  2. Benefits of Opioids for Pain • Opioids “take the edge off pain” or “make it easier to manage it” • Opioids do not eliminate pain, in therapeutic doses

  3. Goals of Opioid Use • In Cancer Pain: Improved Quality of Life • Relief of suffering, even if there is sedation, etc. • In Nonmalignant Pain: Improved Function

  4. Timing • Short-acting/Rescue medications: codeine, hydrocodone, oxycodone, morphine Drug level time

  5. Problems with Short-acting Medications Drug level Loaded In pain Time

  6. Long-acting narcotics: Drug level Time • Fentanyl patches (Duragesic) • Methadone • MS Contin • OxyContin • Need to be dosed on a schedule, not prn

  7. Side Effects of Opioids • Nausea and Vomiting • Constipation • Sedation- sleepiness • Respiratory depression • Urinary retention (difficulty peeing) • Dysphoria – depression • Gonadal atrophy • Myoclonus, muscular rigidity • Increase in Pain Sensitivity

  8. Opioid-induced Hyperalgesia • Animal studies show that repeated opioid administration. . . can lead to a progressive and lasting reduction of baseline nociceptive thresholds, resulting in an increase in pain sensitivity. • The decreased baseline nociceptive thresholds lasted as long as 5 days after the cessation of four fentanyl bolus injections

  9. Opioid-induced Hyperalgesia • Six chronic low back pain patients were assessed for both opioid tolerance and opioid-induced hyperalgesia using quantitative sensory testing (cold and heat) before and after the institution of oral morphine therapy. • Preliminary results showed hyperalgesia and tolerance with cold but no hyperalgesia with heat or analgesic tolerance to heat pain. • Chu L.F., Clark D.J., Angst M.S.:  Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.  J Pain 7. (1): 43-48.2006

  10. Opioid-induced Hyperalgesia • Patients treated intraoperatively with remifentanil reported more postoperative pain than the matched nonopioid controls • Vinik H.R., Igor K.:  Rapid development of tolerance to analgesia during remifentanil infusion in humans.  Anesth Analg 86. 307-311.1998; Crawford M.W., Hickey C., Zaarour C., et al:  Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery.  Anesth Analg 102. (6): 1662-1667.2006;  • Guignard B., Bossard A.E., Coste C., et al:  Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requiremnt.  Anesthesiology 93. (2): 409-417.2000; 

  11. Opioid-induced Hyperalgesia • A number of case reports document decreases in pain with stopping opioids • Wilson G.R., Reisfield G.M.:  Morphine hyperalgesia: a case report.  Am J Hosp Palliat Care 20. (6): 459-461.2003 Mercadante S., Ferrera P., Villari P., et al:  Hyperalgesia: an emerging iatrogenic syndrome.  J Pain Symptom Manage 26. (2): 769-775.2003;  • Heger S., Maier C., Otter K., et al:  Morphine induced allodynia in a child with brain tumour.  BMJ 319. (7210): 627-629.1999;  • Sjogren P., Jensen N.H., Jensen T.S.:  Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with opioid agonists.  Pain 59. 313-316.1994; • Mechanism may be NMDA receptor-mediated central sensitization

  12. Some Definitions • Tolerance is a state resulting from regular use of opioid(s) in which an increased dose of the substance is needed to produce the desired effect. • Physical dependence is a physiologic state of adaptation to a specific opioid(s) characterized by the emergence of a withdrawal syndrome during abstinence, which may be relieved in total or in part by re-administration of the substance.

  13. Definitions • Withdrawal syndrome is a specific constellation of signs and symptoms due to the abrupt cessation of, or reduction in, a regularly administered dose of opioid(s). • Pseudoaddiction – Medication-seeking behaviors that arise as a result of pain being poorly controlled

  14. Definitions • Addiction is a disease process involving use of opioid(s) wherein there is a loss of control, compulsive use, and continued use despite adverse social, physical, psychological, occupational, or economic consequences. • Substance abuse is the use of any substance(s) for non-therapeutic purposes; or use of medication for purposes other than those for which it is prescribed.

  15. Control of medication Medications increase quality of life Medications are decreased if side effects occur Concerned about medical problem Follow the contract Medications left over Med use not controlled Medications decrease quality of life Medications continued in the face of side effects Lack of concern about medical problems Ignore the contract Never have medication left; often have stories about drug losses and shortages Patients vs. Addicts

  16. Addiction in Patients with Chronic Pain • (1)  Intense desire for the drug and overwhelming concern about its continued availability (psychological dependence) • (2)  Evidence of compulsive drug use • unsanctioned dose escalation • continued dosing despite significant side effects • Use of drug to treat symptoms not targeted by therapy • Unapproved use during period of no symptoms Or – see next slide

  17. Addiction in Patients with Chronic Pain • (3) Evidence of one or more of a group of associated behaviors • manipulation of the treating physician or medical system for the purposes of obtaining additional drug (altering prescriptions, for example) • Acquisition of drugs from other medical sources or from a nonmedical source • Drug hoarding or sales • Unapproved use of other drugs (particularly alcohol or other sedatives/hypnotics) during opioid therapy

  18. Questions to Ask: • Is the person’s day centered around taking medication? • Does the person take pain medication only on occasion, perhaps three or four pills per week? • Have there been any other chemical (alcohol or drug) abuse problems in the person’s life? • Does the person in pain spend most of the day resting, avoiding activity, or feeling depressed? • Is the pain person able to function (work, household chores, and play) with pain medication in a way that is clearly better than without?

  19. Signs Someone Is Being Harmed More Than Helped by Pain Medication • Sleeping too much or having days and nights confused • Decrease in appetite • Inability to concentrate or short attention span • Mood swings (especially irritability) • Lack of involvement with others • Difficulty functioning due to drug effects • Use of drugs to regress rather than to facilitate involvement in life • Lack of attention to appearance and hygiene

  20. Addiction Issues with Non-Opioids • Many of the same questions apply when looking at use of • Muscle Relaxants • Cannabis • Other adjunctive medications – • Anticonvulsants • Etc.

  21. Adjunctive Medications • Topical – lidocaine, capsaicin, antiinflammatories, other • Antidepressants • Anticonvulsants • Antiarrhythmic drugs • Ultram

  22. Antidepressants for Pain • Work by affecting neurotransmitters • Do not only work for treating pain by improving depression. • Work as well in non-depressed people as in people with depression • Effectiveness for pain does not correlate with effectiveness for depression • Do not work for all types of pain.

  23. Stopping or Tapering Opioids • Withdrawal Symptoms • Anxiety/Restlessness • Sweating • Insomnia • Diarrhea • Nausea, vomiting • Yawning, rhinorrhea (runny nose) • Transient increase in pain

  24. Treatment of Withdrawal • Each of the symptoms of withdrawal can be treated, and herbal support is also available for opioid withdrawal • Passionflower • Clonidine • Lomotil • Hydroxyzine • Trazodone • Etc.

More Related